New inhaled treatment tested for cystic fibrosis lung function

NCT ID NCT06478706

Summary

This study tested a new inhaled medication called ETD001 for people with cystic fibrosis. The first part checked if the medication was safe to take for a week. The second part measured whether taking it twice daily for 28 days could improve how well the lungs work, compared to a dummy treatment. A total of 57 adults with stable cystic fibrosis participated.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • All Wales Adult CF Centre

    Cardiff, CF64 2XX, United Kingdom

  • Azienda Ospedaliera Universitaria Integrata Verona

    Verona, 37126, Italy

  • Azienda Ospedaliera Universitaria Meyer

    Florence, 50139, Italy

  • Belfast Health and Social Care Trust

    Belfast, BT9 7AB, United Kingdom

  • CF-Studienzentrum Universitätsklinikum Köln

    Cologne, 50924, Germany

  • CHU de Montpellier

    Montpellier, 34295, France

  • Charité Universtaetsmedizin

    Berlin, 13353, Germany

  • Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

    Milan, 20122, Italy

  • Hospices Civils de Lyon

    Lyon, 69495, France

  • Hôpital Cochin

    Paris, 75014, France

  • Hôpitaux de Toulouse

    Toulouse, 31059, France

  • IKF Pneumologie

    Frankfurt, 60596, Germany

  • IRCCS Istituto Giannina Gaslini

    Genova, 16147, Italy

  • LMU Kinikum

    Munich, 80336, Germany

  • Ospedale Pediatrico Bambino Gesù

    Roma, 00165, Italy

  • Queen Elizabeth University Hospital West of Scotland CF Service

    Glasgow, G51 4TR, United Kingdom

  • Royal Brompton Hospital

    London, SW3 6LL, United Kingdom

  • Royal Papworth Hospital

    Cambridge, CB2 0AY, United Kingdom

  • Southampton General Hospital

    Southampton, SO16 6YD, United Kingdom

  • Universitätsklinikum Frankfurt

    Frankfurt, 60590, Germany

  • Westdeutsches Lungenzentrum am Universitätsklinikum

    Essen, 45239, Germany

Conditions

Explore the condition pages connected to this study.